ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Groups agree On Mammography Screening: Money Bill Markups Due After July 4 Recess

June 23, 1989

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Tempero, Johnson Take ASCO Offices

June 6, 2003

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980